PMA device
Ciba Vision (Vasurfilcon A) Soft Contact Lenses
Alcon Laboratories, Inc. · Lenses, Soft Contact, Extended Wear (LPM, Class III) · First FDA decision Jun 10, 2008, newest Apr 13, 2010Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
12
Naming "Ciba Vision"
MAUDE reports
1
Brand "Ciba Vision", since 2015
PubMed studies
113
Mentioning "Ciba Vision"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ciba Vision (Vasurfilcon A) Soft Contact Lenses
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- CIBA VISION (VASURFILCON A) SOFT CONTACT LENSESPMA supplement
P940013-S010 · Decided Apr 13, 2010 · 48 days after receipt · Normal 180 Day Track No User Fee
Device type: Lenses, soft contact, extended wear (LPM) · Ophthalmology
- CIBA VISION EXTENDED WEAR SOFT CONTACT LENSESPMA supplement
P010019-S009 · Decided Jun 10, 2008 · 64 days after receipt · Normal 180 Day Track No User Fee
Device type: Lenses, soft contact, extended wear (LPM) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hydrophilic Contact LensesNational determinationOn the books80.4Updated Jun 11, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Ciba Vision", any status and sponsor, newest update first.
Bausch & Lomb IncorporatedNot on our public-company list
NCT01309906 · 66 participants · Start Dec 2010 · Primary completion Jan 2011
Device: Investigational lens; Air Optix Aqua lens · For: Myopia
Sites: Rochester, New York
- A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact LensesPivotal-lookingCompleted
Bausch & Lomb IncorporatedNot on our public-company list
NCT01583868 · 216 participants · Start Apr 2012 · Primary completion Jun 2012
Device: B&L RD2135-01 lens C; B&L RD2135-01 lens D and 2 more · For: Myopia
Sites: Rochester, New York
- Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose SolutionPivotal-lookingCompleted
Bausch & Lomb IncorporatedNot on our public-company list
NCT00636363 · 541 participants · Start Mar 2008 · Primary completion Aug 2008
Device: Bausch & Lomb Multipurpose Solution - Rub Care; Bausch & Lomb Multipurpose Solution - No Rub Care and 1 more · For: Contact Lens Solutions
Sites: Le Roy, New York
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ciba Vision", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code LPM
1,788 reports: 19 malfunction, 1,759 injury, 0 death
Newest reports for this brand
MW5057436 · Received Oct 26, 2015 · Event dated Jan 1, 2012
Device type: Accessories, Soft Lens Products (LPN)
Device problem as coded: Unable to Obtain Readings; Improper or Incorrect Procedure or Method
Patient problem as coded: Pain; Swelling
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0609-2020 · Started Aug 14, 2018
Reason given: The product may be counterfeit and could have microbial issues.
Cause as FDA categorized it: Counterfeit · Device type: Lenses, Soft Contact, Extended Wear (LPM)
Z-1821-2020 · Started Aug 1, 2018
Reason given: Potentially counterfeit products in/and counterfeit packaging were imported to the U.S.
Cause as FDA categorized it: Counterfeit · Device type: Lenses, Soft Contact, Extended Wear (LPM)
Published research
The most relevant PubMed records for "Ciba Vision"[tiab]. The summary above synthesizes these.
- SynergEyes lenses for keratoconus.
Abdalla YF, Elsahn AF, Hammersmith KM, et al. · Cornea · 2010
- Prostaglandin analogs in the treatment of glaucoma.
Hejkal TW, Camras CB · Semin Ophthalmol · 1999Research Support, Non-U.S. Gov't, Review
- Spherical aberration in contact lens wear.
Lindskoog Pettersson A, Jarkö C, Alvin A, et al. · Cont Lens Anterior Eye · 2008
- Daily cost of beta-adrenergic blocker therapy.
Stewart WC, Sine C, Cate E, et al. · Arch Ophthalmol · 1997Research Support, Non-U.S. Gov't
- Dryness and discomfort with silicone hydrogel contact lenses.
Fonn D, Dumbleton K · Eye Contact Lens · 2003Clinical Trial, Comparative Study
- Corneal topography and soft contact lens fit.
Young G, Schnider C, Hunt C, et al. · Optom Vis Sci · 2010Comparative Study, Research Support, Non-U.S. Gov't
- Predisposing factors for solution-induced corneal staining.
Young G, Canavan K, Jones S, et al. · Optom Vis Sci · 2012Comparative Study, Multicenter Study
- Clinical presentation of intraocular lens schisis.
Neuhann IM, Neuhann TF, Kleinmann G, et al. · J Cataract Refract Surg · 2006
- In vitro effects of selected contact lens care solutions on Acanthamoeba castellanii strains in Poland.
Padzik M, Chomicz L, Szaflik JP, et al. · Exp Parasitol · 2014
- [Influence of topically applied iodides on urinary iodine excretion and thyroid function].
Stankiewicz A, Siekierzyski M, Wierzbowska J · Klin Oczna · 2003Clinical Trial, English Abstract
- Analysis of P. aeruginosa disinfectant sensitivity and microbial adhesions to worn cosmetic contact lenses.
Shen EP, Chu HS, Hsieh YT, et al. · Cont Lens Anterior Eye · 2020
- Impact of protein and lipid on neutralization times of hydrogen peroxide care regimens.
Ngo W, Heynen M, Joyce E, et al. · Eye Contact Lens · 2009Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LPM.
- Bausch and Lomb Polymacon Hydrophilic Contact LensesBausch & Lomb, Inc. · PMA 2002
- methafilcon A Soft (Hydrophilic) Extended Wear Contact LensesCooperVision, Inc. · PMA 2019
- Biofinity (Confilcon A) Soft Contact LensesCooperVision, Inc. · PMA 2012
- Sofmed® breathables XW NEXTCooperVision, Inc. · PMA 2025
- up&up Monthly Performance +CooperVision, Inc. · PMA 2025
- VISTAKON® (etafilcon A) Brand Contact LensesVistakon, Johnson & Johnson Vision Products, Inc. · PMA 2022
- VISTAKON® (senofilcon A) Brand Contact LensesVistakon, Division of Johnson & Johnson Vision Car · PMA 2022
- Ethos AquaTech Monthly XR, Ethos AquaTech Monthly XR for AstigmatismCooperVision, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.